• Optimizing Opioid Receptor Assays with nor-Binaltorphimine d

  2026-06-23

  This article addresses real-world pain points in opioid receptor signaling research, focusing on how nor-Binaltorphimine dihydrochloride (SKU B6269) enhances assay reliability and mechanistic insights. Through scenario-driven Q&A, we discuss best practices for experimental design, protocol optimization, data interpretation, and supplier selection—grounded in recent literature and practical laboratory experience.

• Necrosulfonamide (SKU B7731): Reliable MLKL Inhibition in As

  2026-06-23

  This article addresses real-world laboratory challenges in cell death pathway research and demonstrates how Necrosulfonamide (SKU B7731) provides robust, reproducible solutions for necroptosis assays. Scenario-driven Q&A blocks clarify NSA’s advantages for workflow sensitivity, specificity, and data reliability in cancer and neurodegenerative disease models.

• Magneto-Piezoelectric Scaffolds Activate JAK2-STAT3 in Bone

  2026-06-22

  Wu et al. developed multifunctional scaffolds integrating dual-responsive nanoparticles to disrupt bacterial biofilms and activate oxidative phosphorylation in Icam1+ macrophages, thereby enhancing bone regeneration in infectious bone defects. This strategy bridges infection control and immune-metabolic modulation, offering a new paradigm for tissue repair interventions.

• Maraviroc (UK-427857): Translational Leverage from HIV to Ne

  2026-06-22

  This thought-leadership article explores the mechanistic and translational applications of Maraviroc (UK-427857), a potent CCR5 antagonist, in HIV-1 entry inhibition and emerging neuroinflammation models. Integrating recent findings, protocol guidance, and strategic insights, it empowers researchers to bridge antiviral and immunological disciplines using APExBIO's Maraviroc as a platform molecule.

• Panobinostat Targets Epigenetic Vulnerabilities in MLL-ALL

  2026-06-21

  The reference study demonstrates that panobinostat, a histone deacetylase inhibitor, exerts potent anti-leukaemic effects in vivo against MLL-rearranged acute lymphoblastic leukaemia (ALL) by targeting the RNF20/RNF40/WAC-H2B ubiquitination axis. These insights highlight an epigenetic vulnerability in this aggressive infant leukaemia subtype, providing a strong rationale for further translational research and targeted therapy development.

• Firefly Luciferase mRNA with 5-moUTP: Boosting Assay Precisi

  2026-06-20

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) delivers high-efficiency, low-immunogenicity bioluminescent assays and is purpose-built for reliable in vitro or in vivo mRNA delivery. Its optimized cap structure and 5-moUTP modification set a new standard for translation efficiency, stability, and reproducible gene expression studies.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Biomolec

  2026-06-19

  Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides through amino group conjugation, supporting sensitive detection in imaging and quantification workflows. It is best suited for protocols compatible with organic co-solvents like DMSO or DMF, and is not recommended for applications with water-sensitive proteins or where water solubility is critical.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe): Protocols

  2026-06-19

  Angiotensin II (SKU A1042) enables precise modeling of hypertension mechanisms and cardiovascular remodeling in cell-based and animal experiments. Researchers can use this peptide to study vascular smooth muscle cell hypertrophy and abdominal aortic aneurysm models, provided protocols and storage guidelines are strictly followed. Not intended for diagnostic or clinical applications.

• Tacalcitol-Induced NGF Expression in Human Keratinocytes

  2026-06-18

  The reference study demonstrates that tacalcitol, a synthetic analog of vitamin D3, robustly induces nerve growth factor (NGF) production in human epidermal keratinocytes. These findings highlight a translational mechanism that could inform topical therapies for peripheral neuropathy and expand the understanding of vitamin D analogs in skin neurobiology.

• SGC-CBP30: Precision Targeting of CREBBP/EP300 in Epigenetic

  2026-06-18

  Explore how SGC-CBP30, a potent CREBBP/EP300 bromodomain inhibitor, is redefining advanced epigenetics and cancer biology research. This article uniquely clarifies its biochemical action and translational impact, with practical guidance for assay optimization.

• Isoprenaline Hydrochloride: Precision Tools for Heart–Brain

  2026-06-17

  Explore the advanced use of Isoprenaline Hydrochloride in dissecting heart–brain axis mechanisms. This article delivers in-depth analysis of β-adrenergic signaling in neurocardiac models, setting new benchmarks for cardiac arrhythmia and PTSD research.

• Ceftolozane-Tazobactam Innovations for Resistant Pneumonia M

  2026-06-17

  The referenced study introduces ceftolozane-tazobactam as a structurally advanced cephalosporin-beta-lactamase inhibitor combination for multidrug-resistant nosocomial pneumonia. Its unique molecular design and pharmacodynamics yield high efficacy against Pseudomonas aeruginosa and Enterobacteriaceae, with significant implications for infection model research and antibiotic resistance studies.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-06-16

  0.4% Trypan Blue Solution provides a direct, exclusion-based method for distinguishing live from dead cells during cell viability measurement and cytotoxicity assays. It is not intended for diagnostic or clinical use, and should be applied only in research workflows that require reliable live/dead cell discrimination.

• (R,S)-Anatabine: Amyloid-β Inhibition for Alzheimer's Resear

  2026-06-16

  (R,S)-Anatabine is a minor tobacco alkaloid that selectively reduces amyloid-β peptide levels by inhibiting APP β-cleavage and BACE-1 expression. This compound is used in advanced neurodegeneration research, offering reproducible effects in both in vitro and in vivo Alzheimer's disease models.

• Tolazoline in Translational Research: Mechanism, Strategy, a

  2026-06-15

  This thought-leadership article explores the dual mechanistic roles of Tolazoline as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker, offering translational researchers strategic insights for experimental design. Bridging in vitro airway smooth muscle studies and islet function research, it contextualizes Tolazoline’s value beyond conventional product narratives—grounded in evidence, competitive intelligence, and practical guidance. The piece links to APExBIO’s Tolazoline (SKU A8991), references pivotal studies, and articulates forward-looking opportunities for translational science.

442 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page